SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SuperRare

SuperRare ($RARE) is generating significant discussion and high trading volume, with many community members identifying bullish technical patterns and potential for a breakout. While some view its NFT platform fundamentals and tokenomics favorably, others express caution given past volatility and recent token transfers to exchanges. The token's near-complete vesting schedule is also a central talking point, influencing varied market outlooks.

USELESS

USELESS CRYPTO is trending amidst reports of significant accumulation by major crypto whales and its growing presence on top exchanges, including integration with Chainlink CCIP. The community is highly engaged, embracing the token's ironic 'useless' name as a unique and relatable narrative that fuels speculative predictions for a multi-billion market capitalization. Enthusiasts are actively buying dips, anticipating a massive parabolic run and positioning it as a potential leader in the meme coin sector.

Martin Marietta Materials, Inc. is a natural resource-based building materials company, which engages in the provision of aggregates including crushed stone, sand, and gravel through its network of quarries and distribution yards. It operates through the East Group and West Group segments. The East Group segment offers aggregates and asphalt products. The West Group segment focuses on aggregates, cement, downstream products, and paving services. The company was founded on November 12, 1993 and is headquartered in Raleigh, NC.

Martin Marietta Materials, Inc.

Martin Marietta Materials is trending higher amid strong analyst sentiment highlighting its robust pricing power and increased shipments in the construction materials sector. Community discussion centers on the company's strategic portfolio optimization, including recent acquisitions and divestitures, positioning it as a key beneficiary of sustained government infrastructure spending. This focus on high-margin aggregates is resonating with investors, who see continued strength in its core business.

LendingClub Corp. engages in the operations of digital marketplace bank. It operates through the LendingClub Bank and LendingClub Corporation (Parent Only) segments. The LendingClub Bank segment involves the provision of full complement of financial products and solutions, loans, leases, and deposits. The LendingClub Corporation (Parent Only) segment includes the holding company legal entity. The company was founded by Renaud Laplanche and Soulaiman Htite in 2006 and is headquartered in San Francisco, CA.

LendingClub Corp

LendingClub is experiencing heightened interest following a significant upgrade from J.P. Morgan and the announcement of a substantial stock repurchase program. The community is actively discussing these catalysts, alongside the company's strategic expansion into home improvement lending and upcoming rebranding efforts. Many view LC as a robust, undervalued fintech poised to benefit from a more favorable interest rate environment.

JERRY (JYAI) is a Matt Furie's artistic style; it features an AI-powered content creation hub that produces community-driven video series and art.  Jerry the Turtle, created by Matt Furie, is a character inspired by Furie’s artistic style. JERRY is also an AI-driven meme coin with an ambitious vision. The goal is to establish an AI-powered production house dedicated to creating a video series or episodes featuring characters from Matt Furie’s universe alongside those from Jerry’s world.  This unique blend of characters aims to produce the ultimate crypto-based series. Additionally, we are developing an app that will offer an exclusive, ad-free video series featuring characters from both Matt Furie’s creations and the Jerry Universe. Users will be able to download and share videos directly through the platform.  But that’s not all! A special Jerry Art Panel will showcase original Jerry characters, artwork, and fan creations—free to explore, download, and share with the community.

Jerry The Turtle By Matt Furie

Jerry The Turtle ($JYAI), an AI memecoin from Matt Furie, is heavily trending amid new exchange listings and speculation about a potential Netflix series, fueling massive community interest. Supporters are eagerly discussing its potential to replicate the success of other major memecoins, emphasizing "diamond hand" holding for "generational wealth" as the project progresses towards further high-tier exchange listings.

Enbridge, Inc. engages in the provision of gas and oil. It operates through the following segments: Liquid Pipelines, Gas Distribution and Storage, Gas Transmission and Midstream, Renewable Power Generation, and Energy Services. The Liquids Pipelines segment consists of common carrier and contract crude oil, natural gas liquids and refined products pipelines and terminals in Canada and the U.S., including Canadian Mainline, Regional Oil Sands System, Southern Lights Pipeline, Spearhead Pipeline, Seaway Crude Pipeline interest, and other feeder pipelines. The Gas Distribution & Storage segment consists of natural gas utility operations, the core of which is Enbridge gas, which serves residential, commercial and industrial customers. It also includes natural gas distribution activities in Quebec and an investment in Noverco, which holds a majority interest in a subsidiary entity engaged in distribution and energy transportation primarily in Quebec. The Gas Transmission & Midstream segment consists of investments in natural gas pipelines, processing and green energy projects, the company's commodity marketing businesses, and international activities. The Renewable Power Generation segment consists primarily of investments in wind and solar power generating assets, as well as geothermal, waste heat recovery, and transmission assets. The Energy Services segment consists of businesses in Canada and the United States including logistical services, refinery supply services and the firm's volume commitments on various pipeline systems. The company was founded on April 30, 1949 and is headquartered in Calgary, Canada.

Enbridge Inc

Enbridge is trending as analysts highlight a brightening outlook for midstream energy, driven by robust natural gas demand from data centers and LNG exports, alongside strategic pipeline expansions. The investment community is focused on its consistent dividend growth and stable, fee-based cash flows, largely secured by long-term contracts. Recent positive legal and project developments further bolster confidence in its predictable income profile within the evolving energy sector.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

The Dow Jones Industrial Average is trending as the market keenly anticipates the Federal Reserve's next moves on interest rates, especially amid widespread discussion regarding potential changes in Fed leadership and broader central bank independence. Mixed signals from recent labor market data are fueling a divided community sentiment, with some traders holding onto hopes for a year-end rally while others warn of an overbought market facing economic uncertainties.

Wishing Well

WISH CRYPTO is trending with its community actively engaged in a weekend event, following recent listings on platforms like CoinGecko and anticipation for its full chart integration on StockTwits. The project is garnering attention for its unique deflationary tokenomics, which includes monthly burns tied to US inflation, and its long-term vision as a "digital wishing well" backed by a mature stock community focused on HODLers.

Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. It operates through the following segments: Generics, Specialty, and AvKARE. The Generics segment relates to oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, and transdermal patches and topicals. The Specialty segment refers to the development, promotion, sale, and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical, and surgical products and services to governmental agencies. The company was founded by Chirag K. Patel and Chintu Patel in 2002 and is headquartered in Bridgewater, NJ.

Amneal Pharmaceuticals Inc - Ordinary Shares - Class A

Amneal Pharmaceuticals is trending due to recent significant FDA approvals, particularly for two denosumab biosimilars, Boncresa and Oziltus, which address substantial bone health and oncology markets. The community sees these and other pipeline advancements as crucial growth catalysts, reinforcing the company's strategic expansion in complex generics and biosimilars.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros is currently trending due to its strong Q3 earnings beat and raised guidance, which has spurred multiple analyst upgrades and price target increases. The company's aggressive expansion strategy, including new store openings and a push into grocery retail and hot food, is resonating with a loyal customer base, despite ongoing community debate about its premium valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Oppenheimer downgraded Mosaic to ‘Perform’ from ‘Outperform’.</li><li>Tight sulfur market conditions are expected to persist into the first half of 2026, continuing to weigh on Mosaic’s outlook, the brokerage firm added.</li><li>Tight credit and increased competition due to an influx of lower-grade phosphate imports from China weighed on demand and margins in Brazil.</li></ul>Mosaic Company (MOS) shares were trading down 4.5% on Friday after the firm said that fertilizer market conditions remained challenging in the fourth quarter (Q4) of 2025, as weaker-than-usual seasonal demand weighed on results.In response, Oppenheimer downgraded Mosaic to ‘Perform’ from ‘Outperform’ and removed the firm’s previous $35 price target following the company’s “weak” preliminary Q4 results.Oppenheimer expects Mosaic to continue making gradual progress on operating rates, but noted there is no clear catalyst to lift fertilizer demand in the current crop year. Tight sulfur market conditions are also expected to persist into the first half of 2026, continuing to weigh on the outlook.Despite the intraday drop, retail sentiment on Stocktwits remained in the ‘bullish’ zone over the past 24 hours.<h2 class="st-heading-2">Q4 Preliminary Update</h2>In North America, fertilizer demand dropped sharply as growers remained under economic pressure and an early winter shortened the fall application season. Phosphates were hit hardest due to lower affordability than potash, with shipments estimated to be down about 20% from a year ago.The weak environment weighed on Mosaic’s results, with Q4 phosphate sales of about 1.3 million tonnes and potash sales near 2.2 million tonnes. In response, the company adjusted its phosphate production and shifted volumes to markets showing stronger demand, keeping overall output in line with the prior quarter, though lower sales and rising inventories pressured cash flow.Conditions in Brazil also worsened, as tighter credit and increased competition, due to an influx of lower-grade phosphate imports from China, weighed on demand and margins. As a result, Mosaic Fertilizantes’ sales fell short of expectations, even as full-year volumes were roughly flat.Looking ahead, Mosaic sees a more favorable setup in 2026, supported by nutrient replenishment needs, government support programs, tightening phosphate markets, and reduced Chinese exports, all of which could help lift demand and prices over time, it said.The company is expected to post its Q4 2025 results on February 24.Over the past year, <a href="https://stocktwits.com/symbol/MOS">MOS stock</a> has declined nearly 2%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-abus-stock-fall-today/cmUlzXeR4BY">ABUS Stock On Track For Biggest Intraday Drop In Over 5 Years – What’s The Issue Around Its Patent In Europe?</a> For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Mosaic Company logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

MOS Stock Sees Red As Cheaper Chinese Imports Weigh On Q4 Operations

Mosaic Company said that fertilizer market conditions remained challenging in the fourth quarter, as weaker-than-usual seasonal demand weighed on results.

Equity

Mosaic Company said that fertilizer market conditions remained challenging in the fourth quarter, as weaker-than-usual seasonal demand weighed on results.


3 Basic Materials Funds to Buy as Cyclical Tailwinds Build

FSDPX, FKRCX and ACGGX stand out as materials funds as cyclical tailwinds, pricing power and commodity demand point to a stronger 2026.

Should You Invest in the State Street Materials Select Sector SPDR ETF (XLB)?

Top-Ranked ETFs to Power Your Portfolio Higher 

With market tailwinds building and optimism returning, these top-ranked ETFs can help investors capture momentum safely.

Notable ETF Outflow Detected - XLB, NEM, ECL, NUE

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Materials Select Sector SPDR Fund (Symbol: XLB) where we have...

Noteworthy ETF Outflows: XLB, ECL, MLM, FCX

See Which Of The Latest 13F Filers Holds XLY

At Holdings Channel, we have reviewed the latest batch of the 20 most recent 13F filings for the 09/30/2025 reporting period, and noticed that The Materials Select Sector SPDR Fund (Symbol: XLY) was...

US Food and Drug Administration Commissioner Marty Makary said he’s “taking a hard look” at whether Sarepta Therapeutics’ gene therapy, Elevidys, should remain on the market, following recent patient deaths involving the treatment.&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="http://stockwits.com/symbol/SRPT">Sarepta’s stock</a> plummeted more than 26% in midday trade on Friday. However, on Stocktwits, retail sentiment around the company remained in ‘extremely bullish’ territory amid ‘extremely high’ levels of chatter.A separate&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-request-sarepta-stop-all-shipments-gene-therapy-elevidys-source-says-2025-07-18/#:~:text=The%20FDA's%20request%20follows%20the,condition%20called%20Duchenne%20muscular%20dystrophy.">report</a> by Reuters said that the FDA plans to request Sarepta to stop all shipments of Elevidys voluntarily.Makary’s comments during an&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-07-18/fda-is-investigating-if-sarepta-s-elevidys-should-stay-on-market">interview</a> with Bloomberg come after the company on Thursday disclosed a&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/sarepta-draws-wall-street-ire-after-third-patient-death-this-year/ch8kMF7R5qY">third patient death</a> in a clinical trial involving a different experimental gene therapy that uses a similar viral delivery system.&nbsp;A company spokesperson&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-07-18/sarepta-says-another-patient-died-after-receiving-gene-therapy">told</a> Bloomberg that a 51-year-old patient died of acute liver failure last month in an early-stage trial of a gene therapy to treat limb-girdle muscular dystrophy.The FDA had already been investigating two earlier deaths linked to Elevidys.The growing number of fatalities is raising questions about the future of Sarepta’s therapies and the regulatory path for gene treatments that use adeno-associated viral (AAV) vectors. Elevidys, which was granted accelerated approval in 2023 for Duchenne muscular dystrophy, has remained on the market under post-approval study requirements.Bloomberg also reported that the latest death resulted in an unusually tense exchange between analysts and Sarepta executives on a Friday call. The same group of analysts reportedly had a call with the company earlier this week about the future of Elevidys, but the firm failed to disclose the third patient death. On Friday, two of the analysts asked executives whether the company was keeping any other fatalities undisclosed.“We are historically a very transparent organization,” said Sarepta CEO Douglas Ingram, according to the report, adding that the company didn’t disclose the third patient death earlier because “it was neither material nor central” to what was being discussed.&nbsp;Sarepta’s stock is down 88% year-to-date and nearly 90% over the past 12 months.Get updates to this developing story directly on Stocktwits.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/grubhub-owner-wonder-reportedly-in-talks-for-500-m-debt-refinancing/ch8kHoKR5qp">Grubhub Owner Wonder Reportedly In Talks For $500M Debt Refinancing</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Sarepta Therapeutics logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

FDA Is Reportedly ‘Taking A Hard Look’ To Evaluate Whether Sarepta’s Gene Therapy Elevidys Should Remain On The Market

The FDA had already been investigating two earlier deaths linked to Elevidys.

President Donald Trump’s confirmation of a 50% tariff on copper imports sent U.S. copper futures and mining stocks – including Freeport-McMoran (FCX) and Southern Copper (SCCO) – sharply higher Tuesday. He also said that tariffs targeting the pharmaceutical and semiconductor sectors would be next on the docket.“We’re going to be announcing pharmaceuticals, chips, and various couple of other things — big one,” Trump told reporters at a White House cabinet meeting. “Now today we’re doing copper… I believe the tariff on copper, we’re going to make it 50%.”U.S. copper futures jumped more than 10% on the news, while&nbsp;<a href="http://stocktwits.com/symbol/FCX">Freeport-McMoran’s stock</a> rallied nearly 5%. On Stocktwits, retail sentiment around Freeport-McMoRan edged higher within ‘bullish’ territory as chatter jumped to ‘high’ levels from ‘normal’ a day ago.&nbsp;<a href="http://stocktwits.com/symbol/SCCO">Southern Copper’s stock</a> also gained more than 1% following the announcement, and&nbsp;In February, the Trump administration launched a Section 232 investigation into copper imports, citing potential national security concerns. That probe is due to conclude by November.During the cabinet meeting, Agriculture Secretary Brooke Rollins also raised alarms about Chinese ownership of U.S. farmland, calling it a “massive national security issue.”&nbsp;She said China has been acquiring land near U.S. military bases and urged Congress to ban such purchases. “There’s an executive order coming and some other things coming behind that,” she added.Despite the tough stance on trade and foreign investment, Trump said U.S.-China relations remain stable. “They’ve been very fair on our trade deal, honestly,” he said, adding that he maintains regular communication with Chinese President Xi Jinping. “I’m getting along with President Xi very well. We speak often.”Markets remained mixed after Trump’s cabinet meeting. The&nbsp;<a href="http://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a> edged 0.05% higher, while the&nbsp;<a href="http://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Index ETF (DIA)</a> remained down by 0.27%. Meanwhile, the&nbsp;<a href="http://stocktwits.com/symbol/QQQ">Invesco QQQ Trust Series 1 (QQQ)</a>, which tracks the tech-heavy Nasdaq 100, gained 0.2%.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-says-eu-trade-deal-two-days-off-predicts-300-b-tariff-revenue/chFvyNrR5WM">Trump Says EU Trade Deal ‘Two Days Off’, Predicts $300B In Tariff Revenue By Year-End</a>

U.S. President Donald Trump speaks to members of the press during a Cabinet Meeting at the White House on July 08, 2025 in Washington, DC. (Photo by Andrew Harnik/Getty Images)

Copper Prices Surge After Trump Says 50% Tariff Is Coming – Pharma And Chip Levies Next

President Donald Trump also said U.S.-China relations remain stable and that he’s getting along with Chinese President Xi Jinping “very well.” 

Goldman Sachs ups S&P 500 targets on supportive policy, long-term earnings outlook

Investing.com -- Goldman Sachs raised its S&P 500 forecasts across the board, reflecting more supportive macro conditions and investor confidence in long-term (LT) earnings growth.

XLB
Materials Select Sector SPDR Fund

Feed

News

Sentiment

Fundamentals

Info

Latest XLB News

XLBMaterials Select Sector SPDR Fund